Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A deep-learning algorithm trained entirely on open-source images has outperformed 136 of 157 dermatologists at classifying melanoma, according to a study running in the May edition of the European Journal of Cancer.
Working with SRI International, the California tech lab that gave the world Siri, mental-health specialists at NYU Langone have developed an AI-based tool that uses voice analysis to diagnose posttraumatic stress disorder—potentially via telemedicine.
The FDA granted GE Healthcare’s Deep Learning Image Reconstruction (DLIR) platform 501(k) clearance April 18, marking the first time the agency has approved a deep learning-based CT image reconstruction technology.
Both low- and high-income women experience significant delays in breast cancer diagnosis and treatment when they’re switched from affordable to high-deductible health plans (HDHPs), according to a study published in Health Affairs.
Months-old health technology startup Theator closed a $3 million seed round April 18, providing the company with the cash flow it needs to power its AI-enabled surgical performance platform.
